RBC Capital initiated coverage of Molina Healthcare with a Sector Perform rating and $216 price target. The firm views Molina as a "high-quality, pure-play" government-sponsored managed care company with a path to $25 in adjusted earnings per share by 2029. However, the firm is cautious on the company's rate recovery assumptions.
